Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Glutathione-S-transferase theta 2 (GSTT2) modulates the tumor microenvironment and the response to BCG immunotherapy in a murine orthotopic model of bladder cancer

ABSTRACT: Glutathione-S-transferase theta 2 (GSTT2) modulates the tumor microenvironment and the response to BCG immunotherapy in a murine orthotopic model of bladder cancer

PROVIDER: PRJNA1186198 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31353072_1.fastq.gz	Fastqsanger.gz
	SRR31353072_2.fastq.gz	Fastqsanger.gz
	SRR31353073_1.fastq.gz	Fastqsanger.gz
	SRR31353073_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Glutathione-S-transferase theta 2 (GSTT2) modulates the tumor microenvironment and the response to BCG immunotherapy in a murine orthotopic model of bladder cancer

Project description:Whilst M. bovis Bacillus Calmette-Guérin (BCG) therapy remains the gold-standard for treatment of high-risk non-muscle invasive bladder cancer (BC), 30-40% of patients fail therapy, resulting in disease recurrence and progression. Loss of glutathione-S-transferase theta 2 (GSTT2) expression has been associated with improved response to fewer instillations of BCG. To understand these responses, wild-type (WT) and GSTT2-knockout (KO) mice were implanted orthotopically with MB49-PSA BC cells, and mice were treated with four weekly BCG instillations, after which the bladders were harvested for single-cell RNA sequencing.

2024-12-11 | GSE281932 | GEO

glutathione s-transferase

Project description:production of glutathione s-transferase from Lactobacillus plantarum Ku720558

| PRJEB33504 | ENA

Glutathione S-transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide-induced ferroptosis in pancreatic ductal adenocarcinoma

Project description:Glutathione S-transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide-induced ferroptosis in pancreatic ductal adenocarcinoma

| PRJNA1271484 | ENA

Glutathione-binding site of a bombyx mori theta-class glutathione transferase.

Project description: Not available

| S-EPMC4029803 | biostudies-literature

Guillardia theta CCMP2712

Project description:Guillardia theta CCMP2712

| PRJNA53577 | ENA

Glutathione S-transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide-induced ferroptosis in pancreatic ductal adenocarcinoma

Project description:Currently, chemotherapy remains a key treatment modality for pancreatic ductal adenocarcinoma (PDAC). However, the emergence of drug resistance limits the chemotherapeutic efficacy. Ferroptosis inhibition plays a significant role in chemotherapy resistance. This study investigates the potential mechanisms of PDAC resistance to arsenic trioxide (ATO) and explores the role of GSTT2 in chemotherapeutic resistance. PDAC cells showed ATO resistance due to inhibition of drug-induced ferroptosis, which was validated in vivo and in vitro. Inhibition of nuclear factor erythroid 2-related factor 2 (Nrf2) did not restore ferroptosis. Transcriptomic analysis showed that GSTT2 is significantly upregulated in ATO-resistant cells, suggesting it is a key factor in drug resistance. GSTT2 is highly expressed in ATO-resistant cells compared to ATO-sensitive cells. Silencing GSTT2 enhances the sensitivity of resistant cells to ATO. Further studies indicate that GSTT2, a downstream target of Nrf2, regulates the expression of glutathione peroxidase 4 (GPX4) and ferritin light chain (FTL). Silencing GSTT2 can enhance drug sensitivity by activating ferroptosis in drug-resistant cells. Our study identifies the Nrf2-GSTT2-GPX4 ferroptosis regulatory axis, demonstrating that GSTT2 is a negative regulator of ATO-induced ferroptosis. The development of therapeutic strategies targeting the Nrf2-GSTT2-GPX4 axis will open new avenues for combating resistance to chemotherapy in PDAC.

2026-06-10 | GSE298845 | GEO

Mechanistic evaluation and transcriptional signature of a Glutathione S-transferase Omega 1 inhibitor

Project description:Glutathione S-transferase omega 1 (GSTO1) is an atypical GST isoform that is overexpressed in several cancers and has been implicated in drug resistance. Currently, no small-molecule drug targeting GSTO1 is under clinical development. In this study we show that silencing of GSTO1 with siRNA significantly impairs cancer cell viability, validating GSTO1 as a potential new target in oncology. We report on the development and characterization of a series of chloroacetamide-containing potent GSTO1 inhibitors. Co-crystal structures of GSTO1 with our inhibitors demonstrate covalent binding to the active site cysteine. These potent GSTO1 inhibitors suppress cancer cell growth, enhance the cytotoxic effects of cisplatin, and inhibit tumor growth in colon cancer models as single agent. Bru-seq-based transcription profiling unraveled novel roles for GSTO1 in cholesterol metabolism, oxidative and endoplasmic stress responses, cytoskeleton, and cell migration. Our findings demonstrate the therapeutic utility of GSTO1 inhibitors as anticancer agents and identify novel cellular pathways under GSTO1 regulation in colorectal cancer.

2016-10-07 | GSE85899 | GEO

Guillardia theta

Project description:Guillardia theta nucleomorph genome sequencing

| PRJNA27847 | ENA

Expression of the Stress-Related Genes for Glutathione S-Transferase and Ascorbate Peroxidase in the Most-Glycinin-Deficient Soybean Cultivar Tousan205 during Seed Maturation.

Project description:Global analyses on gene expression profiles in two soybean species, Nanahomare and Tamahomare was performed using DNA microarray technique. Nanahomare is glycinin deficient species, and is high in free amino acid content. Tamahomare is parent species of Nanahomare. In Nanahomare, stress related genes glutathione S-transferase and ascorbate peroxidase had higher expression than in Tamahomare, which suggests glycinin-deficiency caused stress in soy seeds, and that it lead Nanahomare to increase in free amino acid content. Keywords: storage protein deficiency

2010-06-04 | GSE22158 | GEO

Guillardia theta

Project description:Guillardia theta is a flagellate, unicellular alga

| PRJNA9566 | ENA